Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with LLY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.82%||iShares U.S. Pharmaceutical ETF (IHE)||-23.82 (-13.74%)|
|3.12%||PowerShares Dynamic Pharmaceuticals (PJP)||-9.67 (-12.60%)|
|2.68%||SPDR S&P Pharmaceuticals ETF (XPH)||-13.03 (-21.57%)|
|2.66%||First Trust Morningstar ETF (FDL)||-1.78 (-7.47%)|
|1.94%||FlexShares Ready Access Variable Income Fund (RAVI)||-0.07 (-0.09%)|
Company Description (as filed with the SEC)
Eli Lilly and Company (the "company" or "registrant" or "Lilly") was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. We discover, develop, manufacture, and market products in two business segments--human pharmaceutical products and animal health products. The mission of our human pharmaceutical business is to make medicines that help people live longer, healthier, more active lives. Our vision is to make a significant contribution to humanity by improving global health in the 21st century. Most of the products we sell today were discovered or developed by our own scientists, and our success depends to a great extent on our ability to continue to discover, develop, and bring to market innovative new medicines. Our animal health business, operating through our Elanco division, develops, manufactures, and markets products for both food animals and companion animals. ... More ...
Where does LLY fit in the risk graph?
|Annual EPS Est:||$2.78|
|Quarterly EPS Est:||0.75|